---
title: "China Health Group to Raise HK$25 Million via 48 Million-Share Subscription"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274566032.md"
description: "China Health Group Limited has announced a subscription agreement to issue 48 million new shares at HK$0.53 each, raising approximately HK$25.44 million in gross proceeds. This represents about 3.58% of the current share capital. The transaction is subject to Stock Exchange approval and may lead to moderate dilution for existing shareholders. The latest analyst rating for the stock is a Hold with a price target of HK$0.58. The company operates in the healthcare sector and is listed on the Hong Kong Stock Exchange under stock code 673."
datetime: "2026-02-02T15:09:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274566032.md)
  - [en](https://longbridge.com/en/news/274566032.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274566032.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274566032.md) | [繁體中文](https://longbridge.com/zh-HK/news/274566032.md)


# China Health Group to Raise HK$25 Million via 48 Million-Share Subscription

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

China Health Group ( (HK:0673) ) has issued an announcement.

China Health Group Limited has entered into a subscription agreement with an independent Hong Kong investment holding company to issue 48 million new shares under its existing general mandate at HK$0.53 per share. The new shares will represent about 3.58% of the current share capital (3.46% post-issuance), raising approximately HK$25.44 million in gross proceeds and HK$25.27 million in net proceeds, with the shares ranking pari passu with existing equity; completion remains subject to Stock Exchange approval for listing and dealing in the new shares, and the company has cautioned investors that the transaction may or may not proceed, implying moderate dilution for existing shareholders in exchange for fresh capital to support its operations or financial position.

The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.58 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.

**More about China Health Group**

China Health Group Limited, incorporated in Bermuda and carrying on business in Hong Kong, is listed on the Main Board of the Stock Exchange of Hong Kong under stock code 673. The company operates in the healthcare sector, though this announcement focuses on its capital markets activity rather than detailing its specific healthcare products or services.

**Average Trading Volume:** 814,404

**Technical Sentiment Signal:** Hold

**Current Market Cap:** HK$816.9M

Learn more about 0673 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [CHINA HEALTH (00673.HK)](https://longbridge.com/en/quote/00673.HK.md)

## Related News & Research

- [China Health Group Raises HK$25.27 Million Through New Share Subscription](https://longbridge.com/en/news/277090022.md)
- [Neal Gerber Eisenberg Becomes First Law Firm to Achieve GBI Journey to Net Zero Certification for Both Energy and Carbon](https://longbridge.com/en/news/281402424.md)
- [NGE Capital Sets May 7 In-Person AGM and Moves to Digital Meeting Materials](https://longbridge.com/en/news/281433563.md)
- [Fosun International Holds 2025 Annual Results Presentation: Fosun has the Ability to Navigate Through Cycles | FOSUF Stock News](https://longbridge.com/en/news/281354811.md)
- [CORRECTING and REPLACING Lenovo Announces Global Partnership With David Beckham | LNVGY Stock News](https://longbridge.com/en/news/281160355.md)